Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Dissociative

or Stimulant

or atypical)]]

Use the filters below to narrow your results.

None (59) · Benzedrex (1) · Contrave (US), Mysimba (EU) (1) · DXM (1) · DXO (1) · Spravato (1)

Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · NMDA antagonist (3) · None (2) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · NMDA antagonist; sigma receptor agonist (2) · Norepinephrine–dopamine reuptake inhibitor (2)

Other values:

None (62) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1) · '"`UNIQ--vote-00001567-QINU`"' (1)

None (62) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1) · Week 1: 1 tablet (8/90 mg) PO morning; week 2: 1 tablet AM + 1 PM; week 3: 2 AM + 1 PM; week 4 onward: 2 AM + 2 PM (32 mg naltrexone / 360 mg bupropion/d) (1)

None (62) · 28 mg/device (each dose uses 2 devices) (1) · 8 mg naltrexone / 90 mg bupropion ER tablets (titration-pack design) (1)

None (62) · 32 mg naltrexone / 360 mg bupropion per day (1) · 84 mg per session (1)

None (62) · Intranasal (under direct medical supervision) (1) · Oral (1)

None (62) · Modest appetite suppression within weeks; weight loss over months (1) · Within hours of first administration (1)

None (62) · 12 hours (BID dosing required) (1) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1)

None (62) · Naltrexone ~4 hours (6β-naltrexol metabolite ~13 hours); bupropion ~21 hours'"`UNIQ--ref-00001568-QINU`"' (1) · ~7-12 hours (1)

None (62) · Naltrexone ~5% (oral, extensive first-pass to 6β-naltrexol); bupropion ER ~87%'"`UNIQ--ref-00001569-QINU`"' (1) · ~48% intranasal (1)

None (62) · Avoid; may cause fetal harm (1) · Contraindicated in pregnancy (FDA label).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

None (63) · Rx, Schedule III (US). REMS program required. (1)

Showing below up to 64 results in range #1 to #64.

2

3

4

A

B

Bromantane

C

Caffeine

D

E

H

Hexedrone

I

M

N

O

O-PCE

P

R

RTI-111

S

T

X

Xenon

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"